For the first time, a drug developed at UWM enters FDA clinical trials
For the first time, a compound developed at the Milwaukee Institute for Drug Discovery (MIDD) will enter clinical trials at the U.S. Food and Drug Administration. It’s the first step of testing that, if successful, paves the way for the …